New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 28, 2012
10:30 EDTAMRNHumana posts new policy coverage for Amarin's Vascepa
Humana posted on its website a December 27, 2012 pharmacy policy coverage for Amarin's omega]3 fatty acid agent Vascepa. The insurer said Vascepa may be considered medically necessary when the following criteria are met: The member must be utilizing Vascepa for treatment of severe hypertriglyceridemia and the member must have documentation of previous treatment, intolerance, or contraindication to Lovaza and one of either Fibrate or Nicotinic acid. Humana added that Vascepa will be approved in plan year durations or as determined through clinical review. Reference Link
News For AMRN From The Last 14 Days
Check below for free stories on AMRN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
11:20 EDTAMRNHigh option volume stocks:
High option volume stocks: AMRN EWT HIMX PTEN URBN MTW VPRT MTH OTEX ZLTQ
09:26 EDTAMRNOn The Fly: Pre-market Movers
Subscribe for More Information
09:11 EDTAMRNAmarin up 12% to $1.78 after positive mention by Adam Feuerstein
Subscribe for More Information
09:10 EDTAMRNAmarin mentioned positively by The Street's Adam Feuerstein
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use